Review: taking Neurontin and Atenolol together


Summary

Drug interactions are reported among people who take Neurontin and Atenolol together. This review analyzes the effectiveness and drug interactions between Neurontin and Atenolol. It is created by eHealthMe based on reports of 4,104 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Neurontin and Atenolol >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Neurontin

Neurontin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Neurontin 56,860 users)

Atenolol

Atenolol has active ingredients of atenolol. It is often used in high blood pressure. (latest outcomes from Atenolol 81,414 users)

On Jul, 29, 2016

4,104 people who take Neurontin, Atenolol are studied.


Number of reports submitted per year:

Neurontin and Atenolol drug interactions.

Drug effectiveness over time:

Neurontin:
  • < 1 month: 0.0% - (0 of 10 people)
  • 1 - 6 months: 13.0% - (2 of 15 people)
  • 6 - 12 months: 14.0% - (2 of 14 people)
  • 1 - 2 years: 28.0% - (19 of 67 people)
  • 2 - 5 years: 35.0% - (12 of 34 people)
  • 5 - 10 years: 16.0% - (5 of 31 people)
  • 10+ years: 40.0% - (4 of 10 people)
  • not specified: 0.0% - (0 of 0 people)
Atenolol:
  • < 1 month: 0.0% - (0 of 14 people)
  • 1 - 6 months: 14.0% - (1 of 7 people)
  • 6 - 12 months: 33.0% - (2 of 6 people)
  • 1 - 2 years: 33.0% - (4 of 12 people)
  • 2 - 5 years: 69.0% - (27 of 39 people)
  • 5 - 10 years: 82.0% - (60 of 73 people)
  • 10+ years: 54.0% - (19 of 35 people)
  • not specified: 0.0% - (0 of 2 people)

Drug effectiveness by gender:

Neurontin:
  • female: 25.0% - (34 of 134 people)
  • male: 21.0% - (10 of 47 people)
Atenolol:
  • female: 62.0% - (89 of 142 people)
  • male: 52.0% - (24 of 46 people)

Drug effectiveness by age:

Neurontin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 16.0% - (1 of 6 people)
  • 30-39: 21.0% - (4 of 19 people)
  • 40-49: 36.0% - (9 of 25 people)
  • 50-59: 25.0% - (19 of 76 people)
  • 60+: 20.0% - (11 of 55 people)
Atenolol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 28.0% - (2 of 7 people)
  • 30-39: 57.0% - (11 of 19 people)
  • 40-49: 56.0% - (14 of 25 people)
  • 50-59: 71.0% - (55 of 77 people)
  • 60+: 51.0% - (31 of 60 people)

Most common drug interactions over time *:

< 1 month:
  • dizziness
  • renal failure acute
  • hyperkalaemia
  • aches and pains in bones
  • rib cage pain
  • completed suicide
  • nausea
  • somnolence
  • arthralgia
  • cardiac arrest
1 - 6 months:
  • drug ineffective
  • weight decreased
  • dizziness
  • haemarthrosis
  • hypotension
  • diabetes mellitus
  • rash generalised
  • respiratory failure
  • vision blurred
  • depression
6 - 12 months:
  • arthralgia
  • aplasia pure red cell
  • herpes zoster
  • chest pain
  • drug ineffective
  • fall
  • generalised oedema
  • hyponatraemia
  • pericardial effusion
  • pleural effusion
1 - 2 years:
  • cellulitis
  • hypothyroidism postoperative
  • joint pain
  • aches and pains in bones
  • rib cage pain
  • depression
  • anxiety
  • fall
  • anaemia
  • blood pressure increased
2 - 5 years:
  • anxiety
  • pain
  • pleural effusion
  • suicide attempt
  • chest pain
  • pericardial effusion
  • depression
  • pneumothorax
  • cough
  • drug ineffective
5 - 10 years:
  • cellulitis
  • hypothyroidism postoperative
  • joint pain
  • diarrhoea
  • high blood cholesterol
  • high blood sugar
  • constipation
  • hypertension
  • nausea
  • pain
10+ years:
  • high blood cholesterol
  • high blood sugar
  • diarrhoea
  • pain in extremity
  • muscle spasms
  • anxiety
  • deep vein thrombosis
  • dizziness
  • emotional distress
  • erythema
not specified:
  • pain
  • anxiety
  • nausea
  • dyspnoea
  • arthralgia
  • asthenia
  • oedema peripheral
  • back pain
  • depression
  • fall

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • anxiety
  • pain in extremity
  • arthralgia
  • fall
  • oedema peripheral
  • dyspnoea
  • fatigue
  • depression
male:
  • pain
  • anxiety
  • dyspnoea
  • osteonecrosis of jaw
  • asthenia
  • drug ineffective
  • oedema peripheral
  • diabetes mellitus
  • back pain
  • myocardial infarction

Most common drug interactions by age *:

2-9:
  • cardiac failure congestive
  • erythema nodosum
  • hypotension
  • ventricular hypertrophy
  • anaphylactic reaction
  • drug hypersensitivity
  • drug ineffective
10-19:
  • dehydration
  • gastroenteritis
  • blood creatinine increased
  • blood glucose increased
  • blood urea increased
  • heart transplant rejection
  • incision site abscess
  • infection
  • intestinal obstruction
  • ketoacidosis
20-29:
  • dizziness
  • type 2 diabetes mellitus
  • blood cholesterol increased
  • diabetes mellitus
  • chest pain
  • extrapyramidal disorder
  • glycosuria
  • hyperglycaemia
  • postural orthostatic tachycardia syndrome
  • tremor
30-39:
  • depression
  • anxiety
  • pain
  • asthenia
  • pyrexia
  • blood glucose decreased
  • dizziness
  • headache
  • hypertension
  • muscle spasms
40-49:
  • diabetes mellitus
  • pain
  • depression
  • hypertension
  • anxiety
  • arthralgia
  • diarrhoea
  • nausea
  • myalgia
  • blood glucose increased
50-59:
  • anxiety
  • pain
  • arthralgia
  • nausea
  • injury
  • oedema peripheral
  • emotional distress
  • osteonecrosis of jaw
  • pyrexia
  • hypoaesthesia
60+:
  • pain
  • anxiety
  • dyspnoea
  • nausea
  • fall
  • back pain
  • asthenia
  • pain in extremity
  • dizziness
  • oedema peripheral

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Neurontin and Atenolol?

Can you answer these questions?

More questions for: Neurontin, Atenolol

You may be interested in these reviews

More reviews for: Neurontin, Atenolol

On eHealthMe, Neurontin (gabapentin) is often used to treat pain. Atenolol (atenolol) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.